Study Estimates Incidence of Dupilumab-Related Conjunctivitis Study Estimates Incidence of Dupilumab-Related Conjunctivitis

The overall incidence rate of conjunctivitis within 6 months of starting treatment was 6.6% in dupilumab users, compared with 3.3% in methotrexate users.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Dermatology News Source Type: news